Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 264.39 M306.36 M267.44 M267.9 M 1.11 B Research & development ———— — Operating income 48.97 M88.1 M49.17 M64.79 M 251.03 M Non-Operating Income, Total 8.44 M1.5 M-1.73 M4.73 M 12.94 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 4.99 M-224 K-4.31 M1.15 M 1.6 M Unusual income/expense 3.45 M1.73 M2.58 M3.58 M 11.34 M Pretax income 24.36 M62.83 M26.35 M39.35 M 152.89 M Equity in earnings ———— — Taxes 17.84 M13.34 M11.71 M12.89 M 55.78 M Non-controlling/minority interest -1.12 M146 K804 K1.41 M 1.24 M After tax other income/expense -2.09 M-1.67 M-1.61 M-598 K -5.96 M Net income before discontinued operations 7.64 M49.34 M13.84 M25.05 M 95.87 M Discontinued operations ———— — Net income 7.64 M49.34 M13.84 M25.05 M 95.87 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 7.64 M49.34 M13.84 M25.05 M 95.87 M Basic earnings per share (Basic EPS) 0.312.010.571.04 3.93 Diluted earnings per share (Diluted EPS) 0.31.950.550.99 3.79 Average basic shares outstanding 24.57 M24.57 M24.26 M24.43 M — Diluted shares outstanding 25.05 M25.3 M25.19 M25.33 M — EBITDA 318.87 M393.37 M327.45 M333.29 M 1.37 B EBIT 314.61 M390.49 M324.56 M319.5 M 1.35 B Cost of revenue 460.48 M554.48 M477.01 M514.97 M 2.01 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 4.25 M2.88 M2.89 M13.79 M 23.81 M